You are here: Industry Insights > joint venture

News List

Dissolution of Bracco-Eisai Joint Venture PharmaSources
February 21, 2023
Bracco Imaging S.p.A. and Eisai Co., Ltd. announced today that the joint venture regarding the company Bracco-Eisai Co., Ltd.
Pfizer, GlaxoSmithKline Announce Joint Venture americanpharmaceuticalreview
August 02, 2019
Pfizer announced the closing of its joint venture with GlaxoSmithKline to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business.
Cipla EU and Jiangsu Acebright enter into joint venture expresspharma
July 18, 2019
Cipla and Jiangsu Acebright Pharmaceutical announced that they have entered into an agreement to set up a joint venture company in the People’s Republic of China.
Cipla EU, Jiangsu Acebright enter into Joint Venture biospectrumasia
July 16, 2019
Cipla (EU) Limited, a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited and Jiangsu Acebright Pharmaceutical Co. Ltd. have announced that they have entered into an agreement to set up a joint venture company ("
GlaxoSmithKline, Pfizer to Form New Consumer Healthcare Joint Venture americanpharmaceuticalreview
December 21, 2018
GlaxoSmithKline has reached agreement with Pfizer to combine their consumer health businesses into a new Joint Venture, with combined sales of approximately $12.7 billion.....
GSK and Pfizer to create consumer healthcare JV pharmatimes
December 20, 2018
GlaxoSmithKline and Pfizer have unveiled plans to combine their consumer health businesses into a new world-leading Joint Venture worth around £9.8 billion.
GSK and Pfizer to create $13bn consumer healthcare joint venture pharmaceutical-technology
December 20, 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to merge their consumer health businesses to create a new joint venture with an estimated £9.8bn ($12.7bn) in annual sales.....
Coeptis Pharma Enters into Agreement to Acquire Elto Pharma firstwordpharma
November 29, 2018
Elto Phama is developing eltoprazine, a serotonergic agonist in Phase 2b development for the treatment of Parkinson's disease levodopa-induced dyskinesias (Parkinson's LID). Elto Pharma is a joint venture between Amarantus Bioscience Holdings, Inc. (OTCPK
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S. fiercepharma
November 09, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the
US and Cuba form biotech joint venture to develop cancer drugs pharmaceutical-technology
September 29, 2018
US and Cuba have formed a biotech joint venture, called Innovative Immunotherapy Alliance, focused on the research and development of cancer drugs to prolong and improve survival of patients.

Previous page 1 2 Next page